The Nextera patent “Multivalent phage display systems and methods” was granted by the USPTO 8.1.2020.
News & Events
January 1st. Dr. Ole Henrik Brekke joined Nextera as the Chief Business Officer. Ole Henrik has a strong track record in developing companies from the idea stage into successful clinical stage.
A better understanding of immunological principles is at the core of Nextera’s efforts to contribute to robust drug development in complex diseases.